Literature DB >> 417169

Improved GLC determination of plasma nitroglycerin concentrations.

P S Yap, E F McNiff, H L Fung.   

Abstract

A specific and quantitative assay for determining nanogram levels of nitroglycerin in plasma was developed. The method involves stabilization of the drug in plasma with silver nitrate, followed by multiple extraction using purified hexane. Isosorbide dinitrate is added as the internal standard. The hexane extract is subsequently concentrated and injected into a glass column packed with 3% SP-2401 on 100--120-mesh Supelcoport at 140 degrees. A 63Ni-electron-capture detector gives a linear response over the range of 0.1--50 ng of nitroglycerin/ml of rat plasma. From spiked samples, the procedure gave a recovery of about 90%. There was little or no interference from the isomeric glyceryl dinitrates and endogenous compounds in rat or human plasma.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 417169     DOI: 10.1002/jps.2600670445

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  14 in total

1.  Difference in nitroglycerin dose-response in the venous and arterial beds.

Authors:  P R Imhof; B Ott; P Frankhauser; L C Chu; J Hodler
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

2.  Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers.

Authors:  P R Imhof; A Sieber; J Hodler; P Müller; B Ott; P Fankhauser; L C Chu; A Gérardin
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

4.  Kinetics of isosorbide dinitrate and relationships to pharmacological effects.

Authors:  H L Fung; E F McNiff; D Ruggirello; A Darke; U Thadani; J O Parker
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

5.  Haemodynamics and plasma concentrations following sublingual GTN and intravenous, or inhaled, isosorbide dinitrate.

Authors:  W Culling; H Singh; A Bashir; B E Griffiths; J J Dalal; D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  1984-02       Impact factor: 4.335

Review 6.  Intravenous glyceryl trinitrate (nitroglycerin). A review of its pharmacological properties and therapeutic efficacy.

Authors:  E M Sorkin; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1984-01       Impact factor: 9.546

7.  Inhibitory effects of glyceryl trinitrate on alpha-adrenoceptor mediated contraction in the human internal mammary artery.

Authors:  G W He; J Shaw; C Q Yang; C Hughes; D Thomson; B McCaughan; P N Hendle; D K Baird
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of organic nitrates.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

9.  Human pharmacological studies of a new transdermal system containing nitroglycerin.

Authors:  P Müller; P R Imhof; F Burkart; L C Chu; A Gérardin
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  Pharmacokinetic studies of various preparations of glyceryl trinitrate.

Authors:  A Bashir; M J Lewis; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.